Market Cap
$20.4B
RS
RELIANCE, INC.
$399.25 ▲ +1.58%
Prev close $393.04Market cap$20.4B
ConsensusHold
12-mo target$408.88 (+2.5%)
▲ Neutral
Analyst conviction 5/10
Insider Selling Cluster (2 insiders)High Impact Filing (8/10)35 New Institutional Positions15 Institutional Exits
Snapshot
The big-picture read on RS right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Buy (50%)
Inst. Holders
50 funds
Inst. Value
$12.1B
Inst. Activity
35 buys / 15 sells
Insider Activity
$0.00 buy / $13.4M sell
Insider Net $
-$13.4M
Social Sentiment
58° Warm
SEC Reports
5
Press Releases
1
Price chart 30d -0.2%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 7, 2026 dark_pool
Dark Pool: RS — 0.3M shares, 17,952 trades
Week starting 2026-09-07. Total ATS volume: 271,483 shares across 17,952 trades.
Aug 26, 2026 Insider
Aug 5, 2026 SEC Colonias Karen Winifred sold 1,542 shares
Director @ $390.13 ($601.6K)
Two senior RS insiders—the CFO and General Counsel—sold a total of $1.30M in open-market sales over a one-week period. W
CLUSTER — Impact 5/10
Jul 31, 2026 Insider
Ajemyan Arthur sold 2,200 shares
SVP, CFO @ $410.11 ($902.2K)
Jul 28, 2026 Insider
Smith William A II sold 962 shares
SVP, General Counsel, Corp Sec @ $413.90 ($398.2K)
Jul 15, 2026 Event
Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01
Class II: Lack of Sterility Assurance
Jun 30, 2026 Inst.
NORGES BANK — NEW
653,621 shares ($244.2M)
Jun 30, 2026 Inst.
JPMORGAN CHASE & CO — ADD
625,356 shares ($235.0M)
Analyst ratings buy % -18.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
50% rate it Buy or better · 18 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 9, 2026 | JP Morgan | MAINTAIN | Neutral | 55% |
| Aug 24, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Jul 27, 2026 | BMO Capital | MAINTAIN | Market Perform | 53% |
| Jul 23, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Jul 15, 2026 | JP Morgan | MAINTAIN | Neutral | 55% |
| Jul 9, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Jun 24, 2026 | Keybanc | MAINTAIN | Overweight | 52% |
| Jun 10, 2026 | JP Morgan | MAINTAIN | Neutral | 55% |
| Jun 4, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Apr 28, 2026 | Seaport Global | MAINTAIN | Buy | 51% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 3 | 6 | 8 | 1 | 0 | 50% | |
| Aug 1, 2026 | 3 | 6 | 8 | 1 | 0 | 50% | |
| Jul 1, 2026 | 3 | 6 | 8 | 1 | 0 | 50% | |
| Jun 1, 2026 | 3 | 6 | 8 | 1 | 0 | 50% | |
| May 1, 2026 | 3 | 6 | 8 | 1 | 0 | 50% | |
| Apr 1, 2026 | 3 | 6 | 9 | 0 | 0 | 50% | |
| Mar 1, 2026 | 3 | 6 | 9 | 0 | 0 | 50% | |
| Feb 1, 2026 | 3 | 8 | 7 | 0 | 0 | 61% |
Price targets
Where 8 covering analysts think RS trades over the next 12 months.
$408.88 +2.5% upside Hold
Current$399.05 Low$390.00 Median$413.50 High$425.00 8 analysts
$390.00$425.00
Analyst rating Hold· 2.6/5 as of Oct 2, 2026
Social media sentiment mood +40.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
58°
Warm
BearishNeutralBullish
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 2 bullish, 1 bearish, 1 mixed, 1 neutral · avg impact 5.8/10.Plus 1 press releases.
BEARISHCLUSTER5/10
Two senior RS insiders—the CFO and General Counsel—sold a total of $1.30M in open-market sales over
Aug 5, 2026
MIXEDINST-CLUSTER5/10
A mixed institutional cluster in RS for 2026-Q1 shows 25 buyers accumulating $103.1M (net +$92.0M) w
Jun 23, 2026
BULLISH8-K8/10
Reliance, Inc. reported strong Q1 2026 results with $4.03B revenue (15.5% YoY growth) and non-GAAP E
Apr 22, 2026
BULLISHPRESS-RELEASE8/10
Reliance, Inc. (RS) reported strong Q1 2026 results with non-GAAP EPS of $5.16, beating consensus of
Apr 22, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 7, 2026
dark_pool
Dark Pool: RS — 0.3M shares, 17,952 trades
Week starting 2026-09-07. Total ATS volume: 271,483 shares across 17,952 trades.
Sep 2, 2026
other
Reliance, Inc. Announces Participation at the 2026 Jefferies Global Industrials Conference
PHOENIX, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Reliance, Inc. (NYSE: RS) announced today that Karla Lewis, President and Chief Executive Officer, and Ste
Aug 31, 2026
dark_pool
Dark Pool: RS — 0.5M shares, 25,331 trades
Week starting 2026-08-31. Total ATS volume: 483,817 shares across 25,331 trades.
Aug 24, 2026
dark_pool
Dark Pool: RS — 0.4M shares, 24,740 trades
Week starting 2026-08-24. Total ATS volume: 378,920 shares across 24,740 trades.
Aug 17, 2026
dark_pool
Dark Pool: RS — 0.7M shares, 28,890 trades
Week starting 2026-08-17. Total ATS volume: 719,051 shares across 28,890 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $6.81 | $6.44–$7.05 | 87.2% | +2.5% | 7↑ 0↓ | $4.7B | 7 |
| Next Q | $5.28 | $4.89–$6.01 | 119.8% | +5.6% | 6↑ 0↓ | $4.3B | 7 |
| Current FY | $23.54 | $23.05–$23.88 | 65.1% | +1.7% | 8↑ 0↓ | $17.7B | 8 |
| Next FY | $23.61 | $21.65–$25.52 | 0.3% | +2.0% | 8↑ 0↓ | $17.4B | 8 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $6.814 | — |
| 7d ago | $6.786 | +0.028 |
| 30d ago | $6.646 | +0.168 |
| 60d ago | $6.633 | +0.181 |
| 90d ago | $5.295 | +1.519 |
Institutional ownership
Which big funds own RS (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $12.1B total value (32,643,520 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 35 institutions added/increased vs 15 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 5,811,245 | $2.2B | 17.9% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3,290,031 | $1.2B | 10.1% | — |
| STATE STREET CORP | 2,625,386 | $980.8M | 8.1% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,308,297 | $862.4M | 7.1% | — |
| Boston Partners | 2,196,803 | $821.8M | 6.8% | — |
| WELLINGTON MANAGEMENT GROUP LLP | 1,330,345 | $497.0M | 4.1% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 953,533 | $355.2M | 2.9% | — |
| FRANKLIN RESOURCES INC | 832,230 | $310.9M | 2.6% | — |
| YACKTMAN ASSET MANAGEMENT LP | 698,566 | $261.0M | 2.1% | — |
| DIMENSIONAL FUND ADVISORS LP | 662,857 | $247.6M | 2.0% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| NORGES BANK | NEW | — | 653,621 | — | $244.2M |
| JPMORGAN CHASE & CO | ADD | 491,460 | 625,356 | +27.2% | $235.0M |
| FMR LLC | TRIM | 807,010 | 301,975 | -62.6% | $112.8M |
| GOLDMAN SACHS GROUP INC | ADD | 209,188 | 282,315 | +35.0% | $105.5M |
| CITADEL ADVISORS LLC | DOUBLED | 41,289 | 275,606 | +567.5% | $103.0M |
| Qube Research & Technologies Ltd | ADD | 159,475 | 249,841 | +56.7% | $93.3M |
| Life Cycle Investment Partners Ltd | ADD | 128,855 | 166,117 | +28.9% | $62.1M |
| JANE STREET GROUP, LLC | DOUBLED | 7,690 | 148,082 | +1825.6% | $55.3M |
| Robeco Institutional Asset Management B.V. | DOUBLED | 63,383 | 139,032 | +119.4% | $51.9M |
| Allianz Asset Management GmbH | ADD | 64,757 | 125,394 | +93.6% | $46.8M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
12 insiders, 31 transactions. Net -$13.4M — $0.00 bought, $13.4M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 26, 2026 | Colonias Karen Winifred | Director | SELL | 1,542 | $390.13 | $601.6K |
| Jul 31, 2026 | Ajemyan Arthur | SVP, CFO | SELL | 2,200 | $410.11 | $902.2K |
| Jul 28, 2026 | Smith William A II | SVP, General Counsel, Corp Sec | SELL | 962 | $413.90 | $398.2K |
| Jul 28, 2026 | Smith William A II | SVP, General Counsel, Corp Sec | SELL | 1,391 | $414.42 | $576.5K |
| May 20, 2026 | Baldwin Lisa | Director | AWARD | 469 | — | — |
| May 20, 2026 | Sznewajs John G | Director | AWARD | 469 | — | — |
| May 20, 2026 | Colonias Karen Winifred | Director | AWARD | 469 | — | — |
| May 20, 2026 | DELLAQUILA FRANK J | Director | AWARD | 469 | — | — |
| May 20, 2026 | Kamsickas James Kevin | Director | AWARD | 469 | — | — |
| May 20, 2026 | Seeger David W | Director | AWARD | 469 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for RS.
Shares short
1,169,690
Settlement Sep 15, 2026
Change vs prior
+10.2%
Semi-monthly cycle
Days to cover
4.3
At avg daily volume
Of shares outstanding
≈2.3%
Estimate — not % of float
All RS filing & press-release reports (6)
- CLUSTER reportAug 5, 2026
- INST-CLUSTER reportJun 23, 2026
- 8-K reportApr 22, 2026
- PRESS-RELEASE reportApr 22, 2026
- PRESS-RELEASE reportApr 8, 2026
- PRESS-RELEASE reportMar 10, 2026